December 29, 2016

Boston Retirement System v. Alexion Pharmaceuticals Inc et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. November 16, 2023

    Alexion Investors Want $31M Atty Fee In Sales Tactics Deal

    Labaton Sucharow LLP and Motley Rice LLC have asked a Connecticut federal judge for roughly $31 million in attorney fees for their work in securing a $125 million settlement for Alexion Pharmaceuticals Inc. shareholders who claimed that the drugmaker caused a double-digit plunge in stock price after its allegedly illegal sales strategy came to light.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS